ArrowMark Financial (BANX)
Invests in banking-related assets centered on regulatory-capital-relief securities.
$20.98
At close−0.17 (−0.80%)
In millions of USD, except per-share figures
| In millions | Q2 FY21Jun 2021 | Q3 FY21Sep 2021 | Q4 FY21Dec 2021 | Q2 FY22Jun 2022 | Q4 FY22Dec 2022 | Q2 FY23Jun 2023 | Q4 FY23Dec 2023 | Q2 FY24Jun 2024 | Q4 FY24Dec 2024 | Q2 FY25Jun 2025 | Q4 FY25Dec 2025 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 4 | 9 | 10 | 12 | 14 | 15 | 15 | 15 | 6 | 12 | 12 |
| Cost of revenue | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
| Gross profit | 8 | 9 | 9 | 10 | 12 | 14 | 15 | 15 | 15 | 4 | 10 | 10 |
| 2 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | −9 | 0 | 3 | |
| 2 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 2 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Operating income | 6 | 3 | 6 | 7 | 9 | 11 | 12 | 12 | 12 | 13 | 9 | 7 |
| 1 | 0 | −1 | −7 | −3 | −1 | −1 | −4 | −2 | −2 | −2 | −1 | |
| Interest income | 7 | 4 | 4 | 10 | 12 | 14 | 28 | 15 | 15 | 13 | 13 | 13 |
| Interest expense | 1 | 0 | 0 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 1 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 7 | 3 | 5 | 0 | 5 | 9 | 12 | 7 | 10 | 10 | 8 | 6 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Net income from continuing operations | 7 | 3 | 5 | 0 | 5 | 9 | 11 | 7 | 9 | 10 | 8 | 6 |
| Net income | 7 | 3 | 5 | 0 | 5 | 9 | 11 | 7 | 9 | 10 | 8 | 6 |
| EPS, basic | $1.12 | $0.44 | $0.32 | $0.02 | $0.74 | $1.28 | $2.84 | $1.05 | $1.30 | $1.44 | $0.97 | $0.60 |
| EPS, diluted | $1.12 | $0.44 | $0.32 | $0.02 | $0.74 | $1.28 | $2.84 | $1.05 | $1.30 | $1.44 | $0.97 | $0.60 |
| Weighted average shares, basic | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 10 |
| Weighted average shares, diluted | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 10 |
| EBITDA | 6 | 3 | 6 | 7 | 9 | 10 | 12 | 12 | 11 | 13 | 9 | 7 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 6 | 3 | 6 | 7 | 9 | 10 | 12 | 12 | 11 | 13 | 9 | 7 |